Cabot Corporation $CBT Shares Bought by LSV Asset Management

LSV Asset Management grew its position in Cabot Corporation (NYSE:CBTFree Report) by 6.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 608,700 shares of the specialty chemicals company’s stock after buying an additional 37,666 shares during the quarter. LSV Asset Management owned 1.14% of Cabot worth $45,652,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Universal Beteiligungs und Servicegesellschaft mbH boosted its holdings in Cabot by 16.4% during the 2nd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 82,861 shares of the specialty chemicals company’s stock valued at $6,215,000 after acquiring an additional 11,655 shares during the period. Cetera Investment Advisers lifted its position in shares of Cabot by 12.2% during the second quarter. Cetera Investment Advisers now owns 21,663 shares of the specialty chemicals company’s stock worth $1,625,000 after purchasing an additional 2,353 shares in the last quarter. SG Americas Securities LLC lifted its position in shares of Cabot by 98.3% during the second quarter. SG Americas Securities LLC now owns 26,273 shares of the specialty chemicals company’s stock worth $1,970,000 after purchasing an additional 13,023 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Cabot by 6.5% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 13,803 shares of the specialty chemicals company’s stock valued at $1,035,000 after purchasing an additional 842 shares during the period. Finally, Fiera Capital Corp grew its holdings in shares of Cabot by 1.3% in the second quarter. Fiera Capital Corp now owns 167,950 shares of the specialty chemicals company’s stock valued at $12,596,000 after purchasing an additional 2,112 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Wall Street Analyst Weigh In

CBT has been the topic of a number of research reports. Mizuho reduced their target price on shares of Cabot from $78.00 to $72.00 and set an “outperform” rating on the stock in a report on Monday. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research note on Wednesday, October 8th. Zacks Research lowered Cabot from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. Finally, UBS Group cut their price target on Cabot from $82.00 to $65.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average target price of $74.00.

View Our Latest Stock Report on CBT

Cabot Price Performance

Cabot stock opened at $60.37 on Wednesday. The stock has a market cap of $3.21 billion, a P/E ratio of 7.89 and a beta of 0.90. The company has a fifty day simple moving average of $70.67 and a 200-day simple moving average of $74.64. Cabot Corporation has a 12-month low of $58.99 and a 12-month high of $115.16. The company has a current ratio of 2.13, a quick ratio of 1.41 and a debt-to-equity ratio of 0.66.

Cabot (NYSE:CBTGet Free Report) last posted its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing the consensus estimate of $1.72 by ($0.02). Cabot had a net margin of 11.14% and a return on equity of 25.68%. The business had revenue of $899.00 million during the quarter, compared to analysts’ expectations of $967.02 million. During the same period last year, the company earned $1.80 EPS. The business’s quarterly revenue was down 10.2% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Equities analysts expect that Cabot Corporation will post 7.57 EPS for the current fiscal year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 12th. Stockholders of record on Friday, November 28th will be given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend is Friday, November 28th. Cabot’s dividend payout ratio (DPR) is 29.95%.

About Cabot

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Featured Stories

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.